Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Chinese Medical Journal|April 1, 2024
Targeted axillary dissection after neoadjuvant chemotherapy for highly selective patients with initial cN1 breast cancer: A single-center prospective trialXiuchun Chen, Zhenduo Lu, Chengzheng Wang, et al.
Translational Psychiatry|February 6, 2025
Individualized resting-state functional connectivity abnormalities unveil two major depressive disorder subtypes with contrasting abnormal patterns of abnormalityKeke Fang, Lianjie Niu, Baohong Wen, et al.
BMC Cancer|February 6, 2025
A comparative study of mitoxantrone hydrochloride injection and technetium-99 m for tracing axillary sentinel nodes in patients with breast cancerDechuang Jiao, Xiuchun Chen, Xianfu Sun, et al.
Therapeutic Advances in Medical Oncology|June 29, 2026
(Neo)adjuvant therapy patterns and outcomes in patients with HR+/HER2+ early breast cancer: a real-world study using the national cancer information database in ChinaJiujun Zhu, Dechuang Jiao, Chengzheng Wang, et al.
RSC Advances|May 6, 2022
Natural deep eutectic solvent supported targeted solid-liquid polymer carrier for breast cancer therapyXianfu Sun, Periyakaruppan Pradeepkumar, Naresh Kumar Rajendran, et al.
Nature Communications|October 20, 2023
Neoadjuvant camrelizumab plus nab-paclitaxel and epirubicin in early triple-negative breast cancer: a single-arm phase II trialChengzheng Wang, Zhenzhen Liu, Xiuchun Chen, et al.
Gland Surgery|January 19, 2023
Effect of the HER-2/CEP17 ratio in IHC 2+/FISH-amplified breast cancer on pathological complete response to neoadjuvant pertuzumab and trastuzumab treatment-a retrospective cohort studyJiabin Wang, Jianghua Qiao, Yuxia Ruan, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2022
Pathological response and predictive role of tumour-infiltrating lymphocytes in HER2-positive early breast cancer treated with neoadjuvant pyrotinib plus trastuzumab and chemotherapy (Panphila): a multicentre phase 2 trialZhenzhen Liu, Chengzheng Wang, Xiuchun Chen, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 16, 2023
A Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted Axillary Lymph Node Dissection Who Need Abemaciclib TherapyHanzhao Yang, Yadong Sun, Peili Wang, et al.
Cancers|September 23, 2022
Neoadjuvant Efficacy of Three Targeted Therapy Strategies for HER2-Positive Breast Cancer Based on the Same Chemotherapy RegimenJiujun Zhu, Dechuang Jiao, Chengzheng Wang, et al.
Pageof 4